Research Identifies a Potential New Path to Developing a Treatment for Chronic Pain

Los Angeles, September 8, 2015 – Targeted Medical Pharma to present new chronic pain research that reveals significant nervous system abnormalities among patients suffering from Fibromyalgia, at the 2015 PainWeek national conference in Las Vegas, Nevada.

The study looked at 329 Fibromyalgia patients and 58 control patients all of whom wore Holter monitors for a 24 hour period to measure nervous system activity. The results of this study showed that patients with Fibromyalgia experience a significant decrease in both nighttime parasympathetic nervous system (PNS) activity and daytime sympathetic nervous system (ANS) activity.

“Patients with Fibromyalgia often suffer from irritable bowel syndrome (IBS), sleep disorders, widespread pain, anxiety and fatigue,” said David Silver M.D. Chief Medical Officer at Targeted Medical Pharma, Board Certified Rheumatologist and former Director of the Cedars Sinai Chronic Pain and Rehabilitation Program. “Understanding that these symptoms can be attributed to a significant decrease in nighttime parasympathetic activity and an overall reduction in autonomic nervous system function in this patient population, will help guide the development of new therapies for Fibromyalgia and other chronic pain syndromes.”

The scientific poster (#115) titled: “Reduction in Parasympathetic Autonomic Nervous System Function in Fibromyalgia Patients,” will be presented by Dr. David Silver on September 10, 2015 at the Garcia Exhibit Hall, located in The Cosmopolitan Hotel in Las Vegas, Nevada.

About Medical Foods

Medical foods are amino acid based, FDA-regulated medications specially formulated to meet the distinct nutritional requirements of disease. Medical foods are specially formulated using ingredients that are Generally Recognized as Safe and are considered by many healthcare professionals to be a safe and effective alternative or adjunct to certain drug therapies for treating pain syndromes, sleep and cognitive disorders, hypertension and obesity without harmful side effects. Medical foods require the ongoing supervision of a physician or licensed healthcare professional. To learn more about medical foods please visit

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. (OTCQB:TRGM) is a Los Angeles based biotechnology company that specializes in the research, develop and commercialization of amino acid based medical foods for the management of pain syndromes, sleep and cognitive disorders, PTSD, obesity and hypertension. The company currently distributes amino acid based medical foods to healthcare providers, pharmacies and hospitals throughout the United States and abroad through a diverse network of sales channels.